AbbVie Announces EPKINLY Listing On Ontario Health (Cancer Care Ontario) Formulary And Quebec's RAMQ For Treatment Of Relapsed Or Refractory Diffuse Large B-Cell Lymphoma In Adult Patients After Two Or More Lines Of Therapy
Author: Benzinga Newsdesk | August 15, 2024 09:15am